| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $270.3M | +22.7% |
| R&D Expense | $76.1M | +16.2% |
| SG&A Expense | $129.4M | +32.1% |
| Operating Income | -$25.2M | -357.8% |
| Pre-tax Income | -$16.7M | -251.0% |
| Income Tax | -$30.7M | +82.2% |
| Net Income | $14.1M | -92.3% |
| EPS (Basic) | $0.20 | -92.4% |
| EPS (Diluted) | $0.20 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $108.0M | -12.0% |
| Short-term Investments | $98.4M | +45.0% |
| Accounts Receivable | $21.3M | +68.0% |
| Inventory | $31.1M | +44.1% |
| Current Assets | $276.3M | +13.7% |
| Total Assets | $526.3M | +14.5% |
| Current Liabilities | $63.7M | +35.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13.3M | +129.1% |
| Capital Expenditures | $130K | +23.8% |
| Investing Cash Flow | -$29.6M | -265.9% |
| Financing Cash Flow | $1.5M | -40.6% |
| Free Cash Flow | $13.2M | +131.0% |
| -92.3% |
| Total Liabilities |
| $87.5M |
| +37.7% |
| Stockholders' Equity | $438.8M | +10.8% |